10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-03-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1827312603990327296 |
---|---|
author | F Muller F Gsottberger S Petkovic A Mackensen L Mellenthin S Völkl G Benintende R Pelzl K Wendland |
author_facet | F Muller F Gsottberger S Petkovic A Mackensen L Mellenthin S Völkl G Benintende R Pelzl K Wendland |
author_sort | F Muller |
collection | DOAJ |
first_indexed | 2024-04-24T21:46:05Z |
format | Article |
id | doaj.art-ad44be3caaee4d0c9e3a844faacfde46 |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-04-24T21:46:05Z |
publishDate | 2024-03-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-ad44be3caaee4d0c9e3a844faacfde462024-03-20T22:15:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262024-03-0112Suppl 110.1136/jitc-2024-ITOC10.810.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunctionF Muller0F Gsottberger1S Petkovic2A Mackensen3L Mellenthin4S Völkl5G Benintende6R Pelzl7K Wendland8University Hospital of Erlangen, Erlangen, Germany1Universitätsklinikum Erlangen, Medizinische Klinik 5, Hämatologie und Onkologie, Erlangen, Germany1University Hospital of Erlangen, Erlangen, Germany1University Hospital of Erlangen, Erlangen, GermanyUniversity Hospital of Erlangen, Erlangen, Germany4Department of Internal Medicine 5 – Hematology/Oncology, University Hospital Erlangen, Erlangen, GermanyUniversitätsklinukum Erlangen, Erlangen, GermanyUniversitätsklinukum Erlangen, Erlangen, GermanyUniversitätsklinukum Erlangen, Erlangen, Germany |
spellingShingle | F Muller F Gsottberger S Petkovic A Mackensen L Mellenthin S Völkl G Benintende R Pelzl K Wendland 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction Journal for ImmunoTherapy of Cancer |
title | 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction |
title_full | 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction |
title_fullStr | 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction |
title_full_unstemmed | 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction |
title_short | 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction |
title_sort | 10 03 long lasting alterations of the immunophenotype and cytokine signature of dlbcl survivors results in persisting immune dysfunction |
work_keys_str_mv | AT fmuller 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction AT fgsottberger 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction AT spetkovic 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction AT amackensen 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction AT lmellenthin 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction AT svolkl 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction AT gbenintende 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction AT rpelzl 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction AT kwendland 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction |